IWM
FBIO icon

IHT Wealth Management’s Fortress Biotech FBIO Stock Holding History

IHT Wealth Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,377
Closed -$181K – 865
2021
Q2 		$181K Hold
3,377
– – 0.01% 884
2021
Q1 		$179K Buy
3,377
+167
+5% +$9.42K 0.01% 786
2020
Q4 		$87K Buy
3,210
+733
+30% +$31.7K 0.01% 724
2020
Q3 		$150K Buy
+2,477
New +$126K 0.02% 614
2020
Q2 		– Sell
-2,486
Closed -$70K – 596
2020
Q1 		$70K Buy
2,486
+1,599
+180% +$53.1K 0.01% 524
2019
Q4 		$34K Buy
+887
New +$22.8K ﹤0.01% 616

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IHT Wealth Management's FBIO Position: Q3 2021 in Review

IHT Wealth Management sold out of Fortress Biotech (FBIO) in Q3 2021, closing a stake of 3,377 shares — an estimated $181K sold.

IHT Wealth Management first reported a position in FBIO in Q4 2019 and held it in 6 quarters. The position peaked at $181K in Q2 2021. 79 funds tracked by Wall St. Rank hold FBIO as of Q3 2021.

  • IHT Wealth Management reported no remaining Fortress Biotech position as of Q3 2021 after selling out during the quarter.
  • IHT Wealth Management sold 3,377 Fortress Biotech shares in Q3 2021, an estimated $181K.
  • IHT Wealth Management first reported a position in Fortress Biotech in Q4 2019 and held it in 6 quarters.
  • IHT Wealth Management's Fortress Biotech position peaked at $181K in Q2 2021.
  • 79 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2021.

Based on IHT Wealth Management's 13F filing for Q3 2021, filed 15 Nov 2021.